Sexual Wellness
PT-141
A melanocortin receptor agonist that acts centrally rather than on vascular pathways.
- Physician reviewed
- 503A pharmacy compounded
- Patient-specific prescription
Formats & pricing
- 10mg vial — reconstituted injectable$300
Pricing reflects the compounded preparation and physician review. Final therapy and dosing are determined only after your intake is reviewed.
Overview
What is PT-141?
PT-141, also known as bremelanotide, is a synthetic melanocortin analog. Unlike PDE5 inhibitors, it acts on central nervous system pathways involved in desire rather than on blood flow.
Mechanism
How it works
PT-141 activates melanocortin receptors — principally MC4R — in the hypothalamus, influencing the neural signaling associated with sexual desire and arousal.
Wellness support
Potential wellness support areas
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
- Explored for libido and desire in men and women
- Discussed where vascular-focused options are insufficient
- Used on demand rather than daily
- Potential support alongside hormone optimization
Administration
Format & dosing
Used as needed, typically dosed several hours before intended activity, via subcutaneous injection or nasal spray.
Labs & monitoring
Labs, testing & monitoring
Your physician determines the final testing requirements for PT-141 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status
Provider Determines Testing
Commonly reviewed at baseline
- Blood pressure review
- Comprehensive metabolic panel (CMP)
- Hormone panel if indicated
Follow-up & monitoring
Blood pressure and tolerance are reviewed after the first doses; labs are repeated only if your physician sees a reason.
Who may not be a candidate
- Pregnancy or nursing
- Active malignancy without oncology clearance
- Known hypersensitivity to the preparation
- Uncontrolled hypertension
- Known cardiovascular disease without clearance
Medication interactions
Your physician reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Safety
Safety & considerations
Compounded, not FDA-approved in this form. Transient nausea, flushing, and blood pressure changes are reported. Patients with uncontrolled hypertension or cardiovascular disease require careful review.
Regulatory status: Off-Label. Evidence level: Established. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed physician after review of your history.
Physician reviewed
Every protocol is approved by a licensed physician.
503A compounded
Prepared by licensed US compounding pharmacies.
Patient-specific Rx
Prescriptions are issued in your name only.
No membership
No concierge fee and no subscription to browse or begin.